BCRX · BioCryst Pharmaceuticals, Inc.
AI read · Good for BCRX
The AI's read
Continued growth in ORLADEYO and the launch of pellets for children give BioCryst more ways to serve patients. The company also described its profits as strong. The report gives no sales or profit figures, so the size of these gains cannot be measured here.